Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

Contact Supplier

Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

7 Drugs in Development

7 Drugs in Development

DIGITAL CONTENT

1 News #PharmaBuzz

media
1 News #PharmaBuzz

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

7DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

API REF. PRICE (USD/KG)

$ 0

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Regulatory FDF Prices

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

API

FDF

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 860174-12-5, Ati-7505, Naronapride [usan:inn], Naronapride free base, Ati7505, Unii-058896b00b

Molecular Formula

C₂₇H₄₁ClN₄O₅

Molecular Weight

537.1 g/mol

InChI Key

VGDDOIZXGFJDRC-VJTSUQJLSA-N

FDA UNII

058896B00B

1 2D Structure

Naronapride

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

[(3R)-1-azabicyclo[2.2.2]octan-3-yl] 6-[(3S,4R)-4-[(4-amino-5-chloro-2-methoxybenzoyl)amino]-3-methoxypiperidin-1-yl]hexanoate

2.1.2 InChI

InChI=1S/C27H41ClN4O5/c1-35-23-15-21(29)20(28)14-19(23)27(34)30-22-9-13-31(17-25(22)36-2)10-5-3-4-6-26(33)37-24-16-32-11-7-18(24)8-12-32/h14-15,18,22,24-25H,3-13,16-17,29H2,1-2H3,(H,30,34)/t22-,24+,25+/m1/s1

2.1.3 InChI Key

VGDDOIZXGFJDRC-VJTSUQJLSA-N

2.1.4 Canonical SMILES

COC1CN(CCC1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCCCC(=O)OC3CN4CCC3CC4

2.1.5 Isomeric SMILES

CO[C@H]1CN(CC[C@H]1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCCCC(=O)O[C@H]3CN4CCC3CC4

2.2 Other Identifiers

2.2.1 UNII

058896B00B

2.3 Synonyms

2.3.1 MeSH Synonyms

1. (3r)-1-azabicyclo(2.2.2)oct-3-yl 6-((3s,4r)-4-((4-amino-5-chloro-2-methoxybenzoyl)amino)-3-methoxy-1-piperidinyl)hexanoate

2. Ati 7505

3. Ati-7505

4. Ati7505

2.3.2 Depositor-Supplied Synonyms

1. 860174-12-5

2. Ati-7505

3. Naronapride [usan:inn]

4. Naronapride Free Base

5. Ati7505

6. Unii-058896b00b

7. Ati 7505

8. 058896b00b

9. (3r)-1-azabicyclo(2.2.2)oct-3-yl 6-((3s,4r)-4-((4-amino-5-chloro-2-methoxybenzoyl)amino)-3-methoxy-1-piperidinyl)hexanoate

10. 1-piperidinehexanoic Acid, 4-((4-amino-5-chloro-2-methoxybenzoyl)amino)-3-methoxy-, (3r)-1-azabicyclo(2.2.2)oct-3-yl Ester, (3s,4r)-

11. Naronapride [usan]

12. [(3r)-1-azabicyclo[2.2.2]octan-3-yl] 6-[(3s,4r)-4-[(4-amino-5-chloro-2-methoxybenzoyl)amino]-3-methoxypiperidin-1-yl]hexanoate

13. Naronapride [inn]

14. Naronapride (usan/inn)

15. Naronapride [who-dd]

16. Schembl731063

17. Chembl2103858

18. Dtxsid401006590

19. 860174-12-5 (free Base)

20. Db05542

21. Hy-121826

22. Cs-0083508

23. Ns00071036

24. D09933

25. Q27236096

26. (3r)-1-azabicyclo(2.2.2)oct-3-yl 6-((3s,4r)-4-((4-amino-5-chloro-2- Methoxybenzoyl)amino)-3-methoxypiperidin-1-yl)hexanoate

27. (r)-quinuclidin-3-yl 6-((3s,4r)-4-(4-amino-5-chloro-2-methoxybenzamido)-3-methoxypiperidin-1-yl)hexanoate

28. 1-piperidinehexanoic Acid, 4-((4-amino-5-chloro-2-methoxybenzoyl)amino)-3-methoxy-, 1-azabicyclo(2.2.2)oct-3-yl Ester, (3s,4r)-

29. 4-amino-n-(1-{6-[(1-azabicyclo[2.2.2]octan-3-yl)oxy]-6-oxohexyl}-3-methoxypiperidin-4-yl)-5-chloro-2-methoxybenzene-1-carboximidic Acid

2.3.3 Other Synonyms

1. Naronapride Free Base

2. Ati-7505

3. Cas 860174-12-5

4. Ati 7505

5. 860174-12-5

2.4 Create Date

2006-10-26

3 Chemical and Physical Properties

Molecular Formula	C₂₇H₄₁ClN₄O₅
Molecular Weight	537.1 g/mol
XLogP3	2.8
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	8
Rotatable Bond Count	12
Exact Mass	g/mol
Monoisotopic Mass	g/mol
Topological Polar Surface Area	106
Heavy Atom Count	37
Formal Charge	0
Complexity	752
Isotope Atom Count	0
Defined Atom Stereocenter Count	3
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Drug and Medication Information

4.1 Drug Indication

Investigated for use/treatment in gastroesophageal reflux disease (GERD) and gastroparesis.

5 Pharmacology and Biochemistry

5.1 MeSH Pharmacological Classification

Serotonin 5-HT4 Receptor Agonists

Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT4 RECEPTORS. (See all compounds classified as Serotonin 5-HT4 Receptor Agonists.)

Drugs in Development